Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?

Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers

(2015) R. Sood et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome

(2015) Tamar Ringel-Kulka et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Tu1859 Various Effects to Intestinal Epithelial Wound Healing by Partially Hydrolyzed Dietary Fiber and Its Intestinal Metabolites Such As Short Chain Fatty Acids

(2015) Kazuhiko Uchiyama et al.   GASTROENTEROLOGY

Gut Microbiota as Potential Orchestrators of Irritable Bowel Syndrome

(2015) Sean M.P. Bennet et al.   Gut and Liver

Isovaleric acid in stool correlates with human depression

(2015) Olga Szczesniak et al.   NUTRITIONAL NEUROSCIENCE

Cognitive Functions and Depression in Patients with Irritable Bowel Syndrome

(2015) Per G. Farup et al.   Gastroenterology Research and Practice

Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers

(2015) Ivana Plavšić et al.   Gastroenterology Research and Practice

Development and Validation of a Biomarker for Diarrhea-Predominant Irritable Bowel Syndrome in Human Subjects

(2015) Mark Pimentel et al.   PLoS One

A biomarker panel and psychological morbidity differentiates the irritable bowel syndrome from health and provides novel pathophysiological leads

(2014) M. P. Jones et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets

(2014) H. L. DuPont   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology

(2014) Niranjana Natarajan et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

(2014) Emma P Halmos et al.   GUT

The short chain fatty acids, butyrate and propionate, have differential effects on the motility of the guinea pig colon

(2014) Norm R. Hurst et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Validating biomarkers of treatable mechanisms in irritable bowel syndrome

(2014) M. Camilleri et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis

(2014) M. Bashashati et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Correlation between the human fecal microbiota and depression

(2014) A. Naseribafrouei et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care

(2013) Alexander C. Ford et al.   GASTROENTEROLOGY

Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

(2013) Yukihiro Furusawa et al.   NATURE

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome

(2013) Iftikhar Ahmed et al.   PLoS One

Is it who you are or what you do that is important in the human gut?

(2013) E. Avershina et al.   Beneficial Microbes

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

(2012) Rebecca M. Lovell et al.   Clinical Gastroenterology and Hepatology

Cytokines and irritable bowel syndrome: Where do we stand?

(2011) Mohammad Bashashati et al.   CYTOKINE

Regulation of Inflammation by Short Chain Fatty Acids

(2011) Marco A.R. Vinolo et al.   Nutrients

Use of serum biomarkers in a diagnostic test for irritable bowel syndrome

(2009) A. J. LEMBO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Irritable bowel syndrome: towards biomarker identification

(2009) Gerard Clarke et al.   TRENDS IN MOLECULAR MEDICINE